Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

This study is ongoing, but not recruiting participants.

Study NCT00017121 Information provided by National Cancer Institute (NCI)

First Received: June 6, 2001 Last Updated: April 2, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)

Publications:

Markovic SN, Suman VJ, Nevala WK, Geeraerts L, Creagan ET, Erickson LA, Rowland KM Jr, Morton RF, Horvath WL, Pittelkow MR. A Dose-Escalation Study of Aerosolized Sargramostim in the Treatment of Metastatic Melanoma: An NCCTG Study. Am J Clin Oncol. 2008 Dec;31(6):573-9.

Markovic SN, Suman VJ, Schaefer P, et al.: Aerosolized sargramostim for the treatment of metastatic melanoma to the lungs. [Abstract] J Clin Oncol 25 (Suppl 18): A-8565, 488s, 2007.